Technical Analysis for DMAC - DiaMedica Therapeutics Inc.

Grade Last Price % Change Price Change
D 9.42 2.95% 0.27
DMAC closed up 2.95 percent on Thursday, April 22, 2021, on 49 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Flat
Historical DMAC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 2.95%
BB Squeeze + Lower Band Touch Range Contraction 2.95%
Lower Bollinger Band Touch Weakness 2.95%
20 DMA Resistance Bearish 3.97%
50 DMA Resistance Bearish 3.97%
MACD Bearish Centerline Cross Bearish 3.97%
Bollinger Band Squeeze Range Contraction 3.97%
Older End-of-Day Signals for DMAC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Resistance about 5 hours ago
20 DMA Resistance about 6 hours ago
Up 5% about 6 hours ago
Rose Above 20 DMA about 7 hours ago
Rose Above 50 DMA about 7 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for neurological and kidney diseases. The company's lead product is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase II clinical trials for the treatment of acute ischemic stroke and kidney injury indications. It is also developing DM199 for the treatment vascular dementia. In addition, the company is developing DM300, which is in pre-clinical stage for the treatment for acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Injury Kidney Disease Stroke Dementia Kidney Diseases Ischemia Kallikrein Ischemic Stroke Pancreatitis

Is DMAC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.88
52 Week Low 3.243
Average Volume 121,505
200-Day Moving Average 6.86
50-Day Moving Average 9.44
20-Day Moving Average 9.46
10-Day Moving Average 9.44
Average True Range 0.55
ADX 7.69
+DI 22.76
-DI 22.71
Chandelier Exit (Long, 3 ATRs ) 8.67
Chandelier Exit (Short, 3 ATRs ) 10.54
Upper Bollinger Band 9.98
Lower Bollinger Band 8.93
Percent B (%b) 0.47
BandWidth 11.09
MACD Line -0.04
MACD Signal Line 0.01
MACD Histogram -0.0416
Fundamentals Value
Market Cap 176.52 Million
Num Shares 18.7 Million
EPS -0.90
Price-to-Earnings (P/E) Ratio -10.53
Price-to-Sales 0.00
Price-to-Book 3.62
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.33
Resistance 3 (R3) 10.30 9.96 10.18
Resistance 2 (R2) 9.96 9.73 9.98 10.13
Resistance 1 (R1) 9.69 9.59 9.83 9.72 10.08
Pivot Point 9.36 9.36 9.43 9.37 9.36
Support 1 (S1) 9.09 9.13 9.22 9.12 8.76
Support 2 (S2) 8.75 8.98 8.77 8.71
Support 3 (S3) 8.48 8.75 8.66
Support 4 (S4) 8.51